The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study.

Doello, Kevin; Mesas, Cristina; Quiñonero, Francisco; Perazzoli, Gloria; Cabeza, Laura; Prados, Jose; Melguizo, Consolacion; Ortiz, Raul

Doello, Kevin; Mesas, Cristina; Quiñonero, Francisco; Perazzoli, Gloria; Cabeza, Laura; Prados, Jose; Melguizo, Consolacion; Ortiz, Raul.

Afiliação

Doello K; Medical Oncology Service, Virgen de las Nieves Hospital, 18014 Granada, Spain.
Mesas C; Instituto Biosanitario de Granada (ibs. GRANADA), 18014 Granada, Spain.
Quiñonero F; Instituto Biosanitario de Granada (ibs. GRANADA), 18014 Granada, Spain.
Perazzoli G; Center of Biomedical Research (CIBM), Institute of Biopathology and Regenerative Medicine (IBIMER), University of Granada, 18100 Granada, Spain.
Cabeza L; Instituto Biosanitario de Granada (ibs. GRANADA), 18014 Granada, Spain.
Prados J; Center of Biomedical Research (CIBM), Institute of Biopathology and Regenerative Medicine (IBIMER), University of Granada, 18100 Granada, Spain.
Melguizo C; Department of Anatomy and Embryology, Faculty of Medicine, University of Granada, 18071 Granada, Spain.
Ortiz R; Instituto Biosanitario de Granada (ibs. GRANADA), 18014 Granada, Spain.

Cancers (Basel) ; 13(13)2021 Jun 25.

Article em En | MEDLINE | ID: mdl-34201986

Palavras-chave

cancer stem cells; combined therapy; gemcitabine; pancreatic cancer; phospho-p38 protein; sodium selenite

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google